PWZ-029, an inverse agonist selective for α5 GABAA receptors, improves object recognition, but not water-maze memory in normal and scopolamine-treated rats

Behavioural Brain Research

Volumn 241, Issue 1, 2013, Pages 206-213

  Milić, Marija ^a   Timić, Tamara ^a   Joksimović, Srdan ^a   Biawat, Poonam ^b   Rallapalli, Sundari ^b   Divljaković, Jovana ^a   Radulović, Tamara ^a   Cook, James M ^b   Savić, Miroslav M ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

GABA; Inverse agonist; Memory; Object recognition; Water maze

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA5; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; PWZ 029; SCOPOLAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONED REFLEX; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; LIGAND BINDING; MAZE TEST; MEMORY DISORDER; MENTAL PERFORMANCE; NONHUMAN; PASSIVE AVOIDANCE; PREDICTION; PRIORITY JOURNAL; RAT; RECOGNITION; SWIMMING;

ANIMALS; BENZODIAZEPINES; DRUG INVERSE AGONISM; GABA-A RECEPTOR AGONISTS; MALE; MAZE LEARNING; MUSCARINIC ANTAGONISTS; RATS; RATS, WISTAR; REACTION TIME; RECEPTORS, GABA-A; RECOGNITION (PSYCHOLOGY); SCOPOLAMINE HYDROBROMIDE;

EID: 84872037944     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.12.016     Document Type: Article

References (54)

1. Brandt A.L., Oakes F.D. Preanesthesia medication: double-blind study of a new drug, diazepam. Anesthesia and Analgesia 1965, 44:125-129.
2. Haslett W.H., Dundee J.W. Studies of drugs given before anaesthesia XIV. Two benzodiazepine derivatives - chlordiazepoxide and diazepam. British Journal of Anaesthesia 1968, 40:250-258.
3. Jensen L.H., Stephens D.N., Sarter M., Petersen E.N. Bidirectional effects of beta-carbolines and benzodiazepines on cognitive processes. Brain Research Bulletin 1987, 19:359-364.
4. Haefely W.E., Martin J.R., Richards J.G., Schoch P. The multiplicity of actions of benzodiazepine receptor ligands. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 1993, 38:S102-S108.
5. Venault P., Chapouthier G., de Carvalho L.P., Simiand J., Morre M., Dodd R.H., et al. Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks. Nature 1986, 321:864-866.
6. Duka T., Edelmann V., Schütt B., Dorow R. Beta-carbolines as tools in memory research: human data with the beta-carboline ZK 93426. Psychopharmacology Series 1988, 6:246-260.
7. Dorow R., Horowski R., Paschelke G., Amin M. Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors. Lancet 1983, 2:98-99.
8. Petersen E.N. DMCM: a potent convulsive benzodiazepine receptor ligand. European Journal of Pharmacology 1983, 94:117-124.
9. Rudolph U., Möhler H. Analysis of GABA(A) receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annual Review of Pharmacology and Toxicology 2004, 44:475-498.
10. Rudolph U., Crestani F., Benke D., Brünig I., Benson J.A., Fritschy J.M., et al. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 1999, 401:796-800.
11. Rudolph U., Crestani F., Möhler H. GABA(A) receptor subtypes: dissecting their pharmacological functions. Trends in Pharmacological Sciences 2001, 22:188-194.
12. Löw K., Crestani F., Keist R., Benke D., Brünig I., Benson J.A., et al. Molecular and neuronal substrate for the selective attenuation of anxiety. Science 2000, 290:131-134.
13. McKernan R.M., Rosahl T.W., Reynolds D.S., Sur C., Wafford K.A., Atack J.R., et al. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nature Neuroscience 2000, 6:587-592.
14. A receptor. Journal of Neuroscience 2002, 22:5572-5580.
15. Crestani F., Keist R., Fritschy J.M., Benke D., Vogt K., Prut L., et al. Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:8980-8985.
16. Savić M.M., Huang S., Furtmüller R., Clayton T., Huck S., Obradović D.I., et al. Are GABA(A) receptors containing alpha5 subunits contributing to the sedative properties of benzodiazepine site agonists. Neuropsychopharmacology 2008, 33:332-339.
17. Savić M.M., Milinković M.M., Rallapalli S., Clayton T., Joksimović S., Van Linn M., et al. The differential role of alpha1- and alpha5-containing GABA(A) receptors in mediating diazepam effects on spontaneous locomotor activity and water-maze learning and memory in rats. International Journal of Neuropsychopharmacology 2009, 12:1179-1193.
18. Evans A.K., Lowry C.A. Pharmacology of the beta-carboline FG-7142, a partial inverse agonist at the benzodiazepine allosteric site of the GABA(A) receptor: neurochemical, neurophysiological, and behavioral effects. CNS Drug Reviews 2007, 13:475-501.
19. Atack J.R., Bayley P.J., Fletcher S.R., McKernan R.M., Wafford K.A., Dawson G.R. The proconvulsant effects of the GABA(A) alpha5 subtype-selective compound RY-080 may not be alpha5-mediated. European Journal of Pharmacology 2006, 548:77-82.
20. Chambers M.S., Atack J.R., Carling R.W., Collinson N., Cook S.M., Dawson G.R., et al. An orally bioavailable, functionally selective inverse agonist at the benzodiazepine site of GABA(A) alpha5 receptors with cognition enhancing properties. Journal of Medicinal Chemistry 2004, 47:5829-5832.
21. Liu R., Hu R.J., Zhang P., Skolnick P., Cook J.M. Synthesis and pharmacological properties of novel 8-substituted imidazobenzodiazepines: high-affinity, selective probes for alpha 5-containing GABA(A) receptors. Journal of Medicinal Chemistry 1996, 39:1928-1934.
22. Quirk K., Blurton P., Fletcher S., Leeson P., Tang F., Mellilo D., et al. [3H]L-655,708, a novel ligand selective for the benzodiazepine site of GABA(A) receptors which contain the alpha 5 subunit. Neuropharmacology 1996, 35:1331-1335.
23. Savić M.M., Clayton T., Furtmüller R., Gavrilović I., Samardzić J., Savić S., et al. PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA(A) receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats. Brain Research 2008, 1208:150-159.
24. Sternfeld F., Carling R.W., Jelley R.A., Ladduwahetty T., Merchant K.J., Moore K.W., et al. Selective, orally active gamma-aminobutyric acidA alpha5 receptor inverse agonists as cognition enhancers. Journal of Medicinal Chemistry 2004, 47:2176-2179.
25. Atack J.R., Bayley P.J., Seabrook G.R., Wafford K.A., McKernan R.M., Dawson G.R. L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABA(A) receptors. Neuropharmacology 2006, 51:1023-1029.
26. Ballard T.M., Knoflach F., Prinssen E., Borroni E., Vivian J.A., Basile J., et al. RO4938581, a novel cognitive enhancer acting at GABA(A) alpha5 subunit-containing receptors. Psychopharmacology 2009, 202:207-223.
27. Collinson N., Atack J.R., Laughton P., Dawson G.R., Stephens D.N. An inverse agonist selective for alpha5 subunit-containing GABA(A) receptors improves encoding and recall but not consolidation in the Morris water maze. Psychopharmacology 2006, 188:619-628.
28. Dawson G.R., Maubach K.A., Collinson N., Cobain M., Everitt B.J., MacLeod A.M., et al. An inverse agonist selective for alpha5 subunit-containing GABA(A) receptors enhances cognition. Journal of Pharmacology and Experimental Therapeutics 2006, 316:1335-1345.
29. Chambers M.S., Atack J.R., Broughton H.B., Collinson N., Cook S., Dawson G.R., et al. Identification of a novel, selective GABA(A) alpha5 receptor inverse agonist which enhances cognition. Journal of Medicinal Chemistry 2003, 46:2227-2240.
30. Nutt D.J., Besson M., Wilson S.J., Dawson G.R., Lingford-Hughes A.R. Blockade of alcohol's amnestic activity in humans by an alpha5 subtype benzodiazepine receptor inverse agonist. Neuropharmacology 2007, 53:810-820.
31. Lynch G., Palmer L.C., Gall C.M. The likelihood of cognitive enhancement. Pharmacology Biochemistry and Behavior 2011, 99:116-129.
32. A receptors containing the alpha5 subunit. Journal of Medicinal Chemistry 2008, 51:3788-3803.
33. Antunes M., Biala G. The novel object recognition memory: neurobiology, test procedure, and its modifications. Cognitive Processing 2012, 13:93-110.
34. D'Hooge R., De Deyn P.P. Applications of the Morris water maze in the study of learning and memory. Brain Research. Brain Research Reviews 2001, 36:60-90.
35. Bevins R.A., Besheer J. Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory'. Nature Protocols 2006, 1:1306-1311.
36. Lieben C.K., Blokland A., Sik A., Sung E., van Nieuwenhuizen P., Schreiber R. The selective 5-HT6 receptor antagonist Ro4368554 restores memory performance in cholinergic and serotonergic models of memory deficiency in the rat. Neuropsychopharmacology 2005, 30:2169-2179.
37. Vorhees C.V., Williams M.T. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nature Protocols 2006, 1:848-858.
38. McNamara R.K., Skelton R.W. Benzodiazepine receptor antagonists flumazenil and CGS 8216 and inverse agonist β-CCM enhance spatial learning in the rat: dissociation from anxiogenic actions. Psychobiology 1993, 21:101-108.
39. Floresco S.B., Jentsch J.D. Pharmacological enhancement of memory and executive functioning in laboratory animals. Neuropsychopharmacology 2011, 36:227-250.
40. Wallace T.L., Ballard T.M., Pouzet B., Riedel W.J., Wettstein J.G. Drug targets for cognitive enhancement in neuropsychiatric disorders. Pharmacology Biochemistry and Behavior 2011, 99:130-145.
41. Ennaceur A., Meliani K. A new one-trial test for neurobiological studies of memory in rats III. Spatial vs. non-spatial working memory. Behavioural Brain Research 1992, 51:83-92.
42. Murray E.A., Richmond B.J. Role of perirhinal cortex in object perception, memory, and associations. Current Opinion in Neurobiology 2001, 11:188-193.
43. Reger M.L., Hovda D.A., Giza C.C. Ontogeny of rat recognition memory measured by the novel object recognition task. Developmental Psychobiology 2009, 51:672-678.
44. Longone P., Impagnatiello F., Guidotti A., Costa E. Reversible modification of GABA(A) receptor subunit mRNA expression during tolerance to diazepam-induced cognition dysfunction. Neuropharmacology 1996, 35:1465-1473.
45. Wan H., Warburton E.C., Zhu X.O., Koder T.J., Park Y., Aggleton J.P., et al. Benzodiazepine impairment of perirhinal cortical plasticity and recognition memory. European Journal of Neuroscience 2004, 20:2214-2224.
46. Bertaina-Anglade V., Enjuanes E., Morillon D., Drieu la Rochelle C. The object recognition task in rats and mice: a simple and rapid model in safety pharmacology to detect amnesic properties of a new chemical entity. Journal of Pharmacological and Toxicological Methods 2006, 54:99-105.
47. Pirker S., Schwarzer C., Wieselthaler A., Sieghart W., Sperk G. GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 2000, 101:815-850.
48. Klinkenberg I., Blokland A. The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neuroscience and Biobehavioral Reviews 2010, 34:1307-1350.
49. Sarter M., Schneider H.H. High density of benzodiazepine binding sites in the substantia innominata of the rat. Pharmacology Biochemistry and Behavior 1988, 30:679-682.
50. Imperato A., Dazzi L., Serra M., Gessa G.L., Biggio G. Differential effects of abecarnil on basal release of acetylcholine and dopamine in the rat brain. European Journal of Pharmacology 1994, 261:205-208.
51. Lindner M.D., Balch A.H., VanderMaelen C.P. Short forms of the reference- and working-memory Morris water maze for assessing age-related deficits. Behavioral and Neural Biology 1992, 58:94-102.
52. Frick K.M., Baxter M.G., Markowska A.L., Olton D.S., Price D.L. Age-related spatial reference and working memory deficits assessed in the water maze. Neurobiology of Aging 1995, 16:149-160.
53. Kawasaki K., Eigyo M., Ikeda M., Kihara T., Koike K., Matsushita A., et al. A novel benzodiazepine inverse agonist, S-8510, as a cognitive enhancer. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1996, 20:1413-1425.
54. Cole B.J., Hillmann M. Effects of benzodiazepine receptor ligands on the performance of an operant delayed matching to position task in rats: opposite effects of FG 7142 and lorazepam. Psychopharmacology 1994, 115:350-357.